Goos N.P. van Muijen

Author

Also Known As

G N P Van Muijen, G N P van Muijen, G N Van Muijen, G N van Muijen, G. Muijen, G. N. P van Muijen, G. N. P. Muijen, G. N. P. VAN MUIJEN, G. N. P. Van Muijen, G. N. P. van MUIJEN

162

Publications

8.2K

Citations

H-Index

121

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Leiden University Roche Pharma AG (Germany)Maastricht University

About

Goos N.P. van Muijen is an author at Radboud University Nijmegen specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	57	4K
2	Natural Sciences	4	4	88
3	Education	1	1	11
4	Engineering	1	1	55
5	Health Sciences	1	1	24

Goos N.P. van Muijen

101

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. I. Jolanda M. de Vries, Daniëlle J. E. B. Krooshoop, Nicole M. Scharenborg, PubMed Adaptive Immune SystemImmunologyDermatologyImmune SystemImmunotherapy	2003	479
Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13 Goos N.P. van Muijen, Dirk J. Ruiter, Werner W. Franke, Experimental Cell Research Cytokeratins NosTumor BiologyMalignant DiseaseMedicineCell Type Heterogeneity	1986	309
<i>nmb</i>, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenografts Marian A. J. Weterman, N.E. Ajubi, Irma M. R. van Dinter, International Journal of Cancer	1995	249
Expression of Functional Chemokine Receptors CXCR3 and CXCR4 on Human Melanoma Cells Mar M. Robledo, Rubén A. Bartolomé, Natividad Longo, Journal of Biological Chemistry Chemokine BiologyImmunologyImmunoeditingCancer BiologyMelanoma Cells	2001	228
Activated Leukocyte Cell Adhesion Molecule/CD166, a Marker of Tumor Progression in Primary Malignant Melanoma of the Skin Léon C.L.T. van Kempen, Joost J. van den Oord, Goos N.P. van Muijen, American Journal Of Pathology Tumor BiologyCancer ImmunosurveillancePrimary Malignant MelanomaMelanomaImmunology	2000	208
Expression and activation of matrix metalloproteinase‐2 (MMP‐2) and its co‐localization with membrane‐type 1 matrix metalloproteinase (MT1‐MMP) correlate with melanoma progression U. Hofmann, Johan R. Westphal, Albert J.W. Zendman, The Journal of Pathology PathologyMelanoma ProgressionDermatologyCancer BiologyTumor Biology	2000	171
Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice Goos N.P. van Muijen, Kees F. J. Jansen, Ine M. H. A. Cornelissen, International Journal of Cancer Nude MouseTumor BiologyOncologyNude MiceMedicine	1991	162
Requirement for the Synergy Site for Cell Adhesion to Fibronectin Depends on the Activation State of Integrin α5β1 Erik H.J. Danen, Shin-ichi Aota, Annemieke A. van Kraats, Journal of Biological Chemistry	1995	161
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression U. Hofmann, J R Westphal, Erwin T. Waas, British Journal of Cancer	1999	159
Differentiation-related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn, and adult epidermis Goos N.P. van Muijen, Sven O. Warnaar, Maria Ponec Experimental Cell Research Skin DevelopmentDevelopmental BiologyAdult EpidermisCutaneous BiologyCytokeratin Expression	1987	158

Page 1